OK Biotech Co., Ltd. (TPE:4155)

OK Biotech Revenue

OK Biotech had revenue of 436.13M TWD in the quarter ending June 30, 2026, with 2.20% growth. This brings the company's total for the last twelve months to 1.54B, down -10.54% year-over-year. In the year 2025, OK Biotech had annual revenue of 1.56B, down -6.81%. That makes OK Biotech the 28,390th largest company in the world by revenue and 1,342nd in Taiwan.

• Revenue (ttm): 1.54B
• Revenue Growth: -10.54%
• P/S Ratio: 1.34
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.07B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Patient Monitoring Equipment 1.80B 100.0%

By Geography

Chart

• America 854.74M 47.4%
• Asia 536.66M 29.7%
• Africa 269.45M 14.9%
• Taiwan 92.41M 5.1%
• Europe 50.96M 2.8%

Fiscal year ended Dec 31, 2025 See the full OK Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.56B	-113.74M	-6.81%
Dec 31, 2024	1.67B	478.05M	40.11%
Dec 31, 2023	1.19B	-291.54M	-19.65%
Dec 31, 2022	1.48B	220.15M	17.43%
Dec 31, 2021	1.26B	-221.04M	-14.89%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error